OpioidSettlementTracker.com is a public interest project created by Christine Minhee, J.D., an attorney, consultant, and advocate for government accountability.

Christine tracks four categories of opioid settlement-related information — settlements reached by U.S. state and local governments, spending and decision-making processes, expenditure reporting, and grantmaking to communities — to independently advise NGOs and federal, state, and local government entities. She maintains this website pro bono.

Christine is a UCSF-Johns Hopkins Bloomberg Opioid Industry Documents Archive National Advisory Committee member and the co-author of OpioidSettlementGuides.com, the definitive encyclopedia of U.S. states’ opioid settlement spending processes (Vital Strategies, 2024).

She launched OpioidSettlementTracker.com in 2019 as a Visiting Scholar at the University of Washington School of Law, where she graduated as the Dean’s Medalist and co-authored “The Cure for America’s Opioid Crisis? End the War on Drugs” (Harvard Journal of Law & Public Policy). She holds a B.A. from Stanford University and is a graduate of the Columbia Publishing Course.

 
 
 

As featured by:

 

With presentations, podcasts, and projects for:

 
 

 

CONTACT

Email and LinkedIn are good ways to get in touch.

See all of Christine’s publicly available press interviews, video interviews, webinars & panels, and podcasts below. | back to top

 

 
 

A NOTE ABOUT USAGE

The information presented by OpioidSettlementTracker.com exists in the public domain, but the compilations themselves belong to me. I create my datasets for public, beneficial uses, so each of them sit under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which allows you to “remix, adapt, and build upon [the above] non-commercially” provided that two things occur: (1) I am credited in the process (“Christine Minhee, J.D., OpioidSettlementTracker.com”), and (2) you license whatever you produce using my help under identical, non-commercial terms. Happy to answer questions over email. All rights reserved.

 
 

 

ON THIS PAGE

 

 
 

OPIOID SETTLEMENT TRACKER IN THE NEWS

Select Press Interviews

“With Big Tobacco’s cautionary tale shadowing these debates, the issue of accountability looms. Who ensures that grantees spend their money appropriately? What sanctions will befall those who color outside the lines of their grants?

So far, the answers remain to be seen. Christine Minhee, a lawyer who runs the Opioid Settlement Tracker, which analyzes state approaches to spending the funds, noted that on that question, the voluminous legal agreements could be opaque.

‘But between the lines, the settlement agreements themselves imply that the political process, rather than the courts, will bear the actual enforcement burden,” she said. “This means that the task of enforcing the spirit of the agreement — making sure that settlements are spent in ways that maximize lives saved — is left to the rest of us.’”

 
 
 

Fast Company spoke to Christine Minhee, founder of OpioidSettlementTracker.com, to understand how the funds are being spent.

FC: What do you think we can do to make sure the funds are spent most effectively?

CM: Accountability. Sunlight is the best disinfectant. The fact that I went to law school informs my answer. You can argue that our opioid crisis is a public health scrouge created by big pharma or a preventable crisis that could have been mitigated had government done a better job (or both!). 

If states and localities are forced to publish their specific expenditures, they’ll stand up straighter as they spend it since they’ll be subject to public scrutiny and save more lives. 

FC: What do you think are the most effective ways of spending the opioid money?

CM: I’m a student of state governments and as such my authority isn’t really situated in particular interventions. However, harm reduction is a great solution to offset political liabilities in the future. It’s the most effective way to comply and make sure money is spent on evidence-based solutions and that the funds reach communities who need it most. 

I do have a full appreciation that harm reduction can chafe depending on the political context of the state you’re in. For example, I’m in Seattle. Harm reduction seems like an obvious choice here. Not so much in Texas. But if you think about it practically, harm reduction is the best way to maximized lives saved as opposed to abstinence education. 

 

See also Christine’s video interviews, webinars & panels, and podcasts. | back to top

 
 

Video Interviews

 

Other video interviews:

Grassroots groups nationwide fight for opioid settlement money” (Spotlight on America) (August 2024)

 
 

See also Christine’s press interviews, webinars & panels, and podcasts. | back to top

 
 

Webinars & Panels

Understanding and Accessing Opioid Settlement Funds: What it Means for Defenders and Communities,” National Association of Criminal Defense Lawyers (December 2024)

Accessing Opioid Settlement Funding for Harm Reduction Programs,” National Harm Reduction Coalition (July 2022)

 
 
 
 

Other webinars and panels:

Will States and Counties Spend Their National Opioid Settlements Effectively?, University of Pennsylvania Leonard Davis Institute of Health Economics (February 2023)

 
 

Ohio’s Opioid Settlement: Proceeds and Plans for Impact, Ohio State University Moritz College of Law Drug Enforcement and Policy Center (December 2021)

Ohio Opioid Settlements: How To Spend $1 Billion Wisely, Harm Reduction Ohio (October 2021)

 
 

See also Christine’s press interviews, video interviews, and podcasts. | back to top

 
 
 

Podcasts

Can $55 Billion End the Opioid Epidemic?” (Freakonomics Radio) (May 2024)

“There’s also a way to track the $55 billion in settlement money — or at least try to track it. That is thanks to this person.

MINHEE: My name is Christine Minhee. I’m the founder of opioidsettlementtracker.com. … I started the project after I got obsessed with the Big Tobacco litigation as a law student, quickly realized that we were hurtling into the same dismal landscape of poor spending with opioid settlements, without any guardrails.”

 
 

Following the Opioid Settlement Money: Interview with Christine Minhee” (Bankruptcy for Billionaires) (December 2023)

“We are pleased to introduce you to Christine Minhee: she makes the world better. Christine Minhee was a law student when she took it upon herself to track opioid litigation settlements and the allocation of this "abatement" fund money. Now, not only do we have her user-friendly website (opioidsettlementtracker.com), but her work has spurred states to become more transparent about their spending.”

Opioid Settlement Funds: ‘Are we on the Right Track?’” (The Addiction Files: An Addiction Medicine Podcast) (November 2024)

“Christine Minhee, JD, founder of OpioidSettlementTracker.com, joins us for an insightful discussion on the distribution of opioid settlement funds. In this episode, Christine delves into the complexities of how these funds are allocated at the state and local levels, providing a clear explanation of key concepts such as "Exhibit E" and the issue of supplantation—where settlement funds may be used to replace, rather than supplement, existing state funding. This conversation provides valuable insights for policymakers, community leaders, and advocates seeking to ensure that settlement funds are used effectively to combat the opioid crisis…”

Episode 40: Christine Minhee on the Promises and Perils of Opioid Litigation” (Drugs and Stuff: A Podcast from the Drug Policy Alliance) (October 2024)

“As overdose deaths continue to increase, where will this money actually go? We sat down with Christine Minhee, an expert on opioid litigation and creator of the opioid settlement tracker: a project that asks, ‘Will opioid settlements actually be spent in ways that bolster the public health response to drug addiction?’ She spoke with Mary Sylla, a senior staff attorney with DPA, about what opioid litigation is, why it’s so complex, how it ties into our current moment, and what her pie in the sky dream for a settlement would look like.”

620 - How The Opioid Settlement Tracker Is Monitoring $50 Billion” (Johns Hopkins Bloomberg School of Public Health: Public Health On Call) (June 2023)

'“Who is making decisions about how to spend more than $50 billion in proceeds from opioid-related litigation? Christine Minhee, lawyer and founder of opioidsettlementtracker.com, talks with Dr. Josh Sharfstein about tracking the complex cashflow state by state, and her hopes that the website will challenge more jurisdictions to share just how they’re spending dollars intended for tackling the opioid epidemic.”

Bonus Episode: Crisis to Empowerment - Opioid Settlement Funds” (VitalTalks: Future of Public Health) (July 2023)

“Christine Minhee, Founder, OpioidSettlementTracker.com and Kate Boulton, Senior Legal Technical Advisor at Vital Strategies, highlight the importance of transparency and public involvement in decision-making processes on how these resources will be used, while discussing how health advocates can access the funds for harm reduction initiatives. Discover how these resources empower individuals and communities to influence the impact of settlement funds on global health.”

#68: Tracking the Opioid Settlements (Christine Minhee)” (The Dr. Junkie Show) (August 2021)

“New York recently announced a $1.8 billion settlement with major drug distributors, and a larger $26 billion "global settlement" scheduled to follow shortly thereafter. But that money won't be devoted to methadone treatment or paying for rehab. It will probably be devoted to making the war on drugs even larger and more violent. This week I sit down with Christine Minhee, author and editor of The Opioid Settlement Tracker, to talk about why this is happening, and how we can prevent the worst of the damage.”

See also Christine’s press interviews, video interviews, and webinars & panels. | back to top

 
 
 

ALL MENTIONS BY DATE

 

2024

 
 

2023

 
 

2022

 
 

 

FREQUENTLY ASKED PROJECT-RELATED QUESTIONS

 
 

Why are you tracking opioid settlements?

 
I think everyone understands why cities and counties have filed their own cases. ... It’s the legacy of the tobacco settlement, when most of the $200 billion that was paid by tobacco manufacturers did not go toward reducing smoking and treating lung cancer[, and] was used by state legislators for other state purposes.
— Judge Polster, the federal district court judge (N.D. Ohio) overseeing the MDL

It’s one thing for attorneys general to claim that states will spend their opioid settlements better than they did their big tobacco MSA winnings. It’s quite another to show exactly how they did or did not. And the importance of spending data related to public health crises — especially those exacerbated by government mismanagement — cannot be understated!

Reports detailing how states have apportioned their big tobacco MSA proceeds, e.g., Broken Promises to Our Children: A State-by-State Look at the 1998 Tobacco Settlement 20 Years Later, and other datasets like it, have been indispensable to local government plaintiffs as they pursue lawsuits alongside their state attorneys general. From those reports, we know the following:

“In the current budget year, Fiscal Year 2020, the states will collect $27.2 billion from the settlement and taxes. But they will spend just 2.7% of it – $739.7 million – on programs to prevent kids from smoking and help smokers quit.

Meanwhile, tobacco companies spend $9.1 billion a year – $1 million every hour – to market their deadly and addictive products. This means tobacco companies spend over $12 to market their products for every $1 the states spend to reduce tobacco use.”

If states misspend the settlements they win from pharmaceutical opioid manufacturers, distributors, and retailers the way they misspent their winnings from big tobacco, the local services and community treatment providers combatting Opioid Use Disorder (OUD) on the ground are likely to receive very, very little of it. Cities, counties, and tribal governments know this, so they sue to ensure their slice of the abatement funding pie.

Do you have a secret agenda?

I think that the war on drugs has failed, and I doubt that federal regulatory agencies are properly incentivized to prioritize the public’s health over the needs of powerful corporations as well as they can be. But otherwise, not really.

Where are you based?

Seattle, Washington.

So you’re a liberal.

Is this going somewhere?

Who pays you?

Since early 2021, no single entity pays me to run this site. I used my Open Society Foundations (OSF) Soros Justice Fellowship grant to launch this project in 2019. (“The opinions expressed herein are the author’s own and do not necessarily express the views of the Open Society Institute,” etc.) When the fellowship ended in 2021, I decided to keep the site going pro bono. I now pay rent by working as an opioid settlement expert and legal consultant to a diverse portfolio of non-profit organizations, associations of governments, and other “non-pharma” entities.

I knew that the salus populi suprema lex in your footer was an Illuminati thing.

It actually means “the welfare of the people is the supreme law.”

How do I reach you?

Email is the fastest way to get in touch: Christine@OpioidSettlementTracker.com. I’m also on LinkedIn.

back to top | back to CONTENTS